Ghost Tree Capital’s Biolase, Inc. BIOL Stock Holding History

Ghost Tree Capital’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-24	Closed	-$270K	–	71
2015 Q3	$270K	Hold	24	–	–	0.12%	73
2015 Q2	$522K	Hold	24	–	–	0.17%	63
2015 Q1	$606K	Hold	24	–	–	0.22%	61
2014 Q4	$789K	Hold	24	–	–	0.38%	55
2014 Q3	$747K	Hold	24	–	–	0.41%	60
2014 Q2	$660K	Hold	24	–	–	0.47%	50
2014 Q1	$723K	Buy	+24	New	+$837K	0.43%	54

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

PCMI

Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ghost Tree Capital's BIOL Position: Q4 2015 in Review

Ghost Tree Capital sold out of Biolase, Inc. (BIOL) in Q4 2015, closing a stake of 24 shares — an estimated $270K sold.

Ghost Tree Capital first reported a position in BIOL in Q1 2014 and held it in 7 quarters. The position peaked at $789K in Q4 2014. 30 funds tracked by Wall St. Rank hold BIOL as of Q4 2015.

Ghost Tree Capital reported no remaining Biolase, Inc. position as of Q4 2015 after selling out during the quarter.
Ghost Tree Capital sold 24 Biolase, Inc. shares in Q4 2015, an estimated $270K.
Ghost Tree Capital first reported a position in Biolase, Inc. in Q1 2014 and held it in 7 quarters.
Ghost Tree Capital's Biolase, Inc. position peaked at $789K in Q4 2014.
30 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2015.

Based on Ghost Tree Capital's 13F filing for Q4 2015, filed 16 Feb 2016.